Research published today (Jan. 22) in the journal Brain reveals a new approach to Alzheimer’s disease (AD) that may eventually make it possible to reverse memory loss, a hallmark of the disease in its late stages.
The team, led by University at Buffalo scientists, found that by focusing on gene changes caused by influences other than DNA sequences — called epigenetics — it was possible to reverse memory decline in an animal model of AD.
“In this paper, we have not only identified the epigenetic factors that contribute to the memory loss, we also found ways to temporarily reverse them in an animal model of AD,” said senior author Zhen Yan, PhD, a SUNY Distinguished Professor in the Department of Physiology and Biophysics in the Jacobs School of Medicine and Biomedical Sciences at UB.
The research was conducted on mouse models carrying gene mutations for familial AD — where more than one member of a family has the disease — and on post-mortem brain tissues from AD patients.
AD is linked to epigenetic abnormality
AD results from both genetic and environmental risk factors, such as aging, which combine to result in epigenetic changes, leading to gene expression changes, but little is known about how that occurs.
The epigenetic changes in AD happen primarily in the later stages, when patients are unable to retain recently learned information and exhibit the most dramatic cognitive decline, Yan said. A key reason for the cognitive decline is the loss of glutamate receptors, which are critical to learning and short-term memory.
“We found that in Alzheimer’s disease, many subunits of glutamate receptors in the frontal cortex are downregulated, disrupting the excitatory signals, which impairs working memory,” Yan said.
The researchers found that the loss of glutamate receptors is the result of an epigenetic process known as repressive histone modification, which is elevated in AD. They saw this both in the animal models they studied and in post-mortem tissue of AD patients.
Yan explained that histone modifiers change the structure of chromatin, which controls how genetic material gains access to a cell’s transcriptional machinery.
“This AD-linked abnormal histone modification is what represses gene expression, diminishing glutamate receptors, which leads to loss of synaptic function and memory deficits,” Yan said.
Potential drug targets
Understanding that process has revealed potential drug targets, she said, since repressive histone modification is controlled or catalyzed by enzymes.
“Our study not only reveals the correlation between epigenetic changes and AD, we also found we can correct the cognitive dysfunction by targeting the epigenetic enzymes to restore glutamate receptors,” Yan said.
The AD animals were injected three times with compounds designed to inhibit the enzyme that controls repressive histone modification.
“When we gave the AD animals this enzyme inhibitor, we saw the rescue of cognitive function confirmed through evaluations of recognition memory, spatial memory and working memory. We were quite surprised to see such dramatic cognitive improvement,” Yan said.
“At the same time, we saw the recovery of glutamate receptor expression and function in the frontal cortex.”
The improvements lasted for one week; future studies will focus on developing compounds that penetrate the brain more effectively and are thus longer-lasting.
Brain disorders, such as AD, are often polygenetic diseases, Yan explained, where many genes are involved and each gene has a modest impact. An epigenetic approach is advantageous, she said, because epigenetic processes control not just one gene but many genes.
“An epigenetic approach can correct a network of genes, which will collectively restore cells to their normal state and restore the complex brain function,” she explained.
“We have provided evidence showing that abnormal epigenetic regulation of glutamate receptor expression and function did contribute to cognitive decline in Alzheimer’s disease,” Yan concluded. “If many of the dysregulated genes in AD are normalized by targeting specific epigenetic enzymes, it will be possible to restore cognitive function and behavior.”
The Latest on: Epigenetics
via Google News
The Latest on: Epigenetics
- Chromatin profiling of cortical neurons identifies individual epigenetic signatures in schizophreniaon October 17, 2019 at 5:28 am
The human genome is decorated by numerous chemical modifications, jointly referred as “epigenetics”. They include direct modifications of DNA bases (for example, methylation of cytosines) and also ...
- Targeting RNA with Epitranscriptomicson October 17, 2019 at 4:51 am
This year, the Targeting RNA Congress, taking place in Frankfurt, Germany, will showcase the latest advancements in direct RNA modulation using small molecules and epigenetics. Academic and industry ...
- Epigenetics Market to Reach USD 19.12 Billion by 2026 | Reports And Dataon October 16, 2019 at 7:41 pm
Epigenetics Market Size - USD 7.10 billion in 2018, Market Growth - CAGR of 13.1%, Epigenetics Industry Trends- Rising prevalence of cancer and other chronic diseases, and increased research funding ...
- New textbook explains human epigenetics to undergraduateson October 16, 2019 at 2:21 pm
The world's first undergraduate textbook on epigenetics focusing on humans has just been released by University of Eastern Finland Professor Carsten Carlberg and Associate Professor Ferdinand Molnár.
- Inherited Learning? It Happens, but How Is Uncertainon October 16, 2019 at 10:36 am
Studies suggest that epigenetics allows some learned adaptive responses to be passed down to new generations. The question is how. As a biological concept, the inheritance of acquired characteristics ...
- Epigenetics Diagnostic 2019 Global Market Outlook,Research,Trends and Forecast to 2024on October 16, 2019 at 5:50 am
The global Epigenetics Diagnostic market is valued at XYZ million USD in 2018 and is expected to reach XYZ million USD by the end of 2024, growing at a CAGR of XYZ% between 2019 and 2024. The ...
- Epigenetics Applications Market Size, Share, Growth, Trends and Forecast 2016-2022on October 16, 2019 at 3:14 am
Oct 16, 2019 (AmericaNewsHour) -- The study of heritable changes in gene expression (active versus inactive genes) that involves changes to the underlying DNA sequence a change in phenotype without a ...
- Rare access to fetal tissue yields valuable insights into autismon October 15, 2019 at 4:04 am
But research with fetal brains poses formidable challenges, both logistical and ethical. As a result, gene expression in fetal brains “is pretty much a black box,” says Jonathan Mill, professor of ...
- Global Epigenetics Industryon October 11, 2019 at 5:34 pm
New York, Oct. 11, 2019 (GLOBE NEWSWIRE) -- Reportlinker.com announces the release of the report "Global Epigenetics Industry" - https://www.reportlinker.com/p05817986/?utm_source=GNW 8%.
- Epigenetics and mental wellnesson October 11, 2019 at 12:43 am
This is the sad yet beautiful science of Epigenetics and Mental Wellness. Aman Iqbal is the Founder at Vantage Enterprise Disclaimer: The views expressed in the article above are those of the authors' ...
via Bing News